GIRK1 Rabbit Monoclonal Antibody

GIRK1 Rabbit Monoclonal Antibody

Cat: AMRe87156
Size:50μL Price:$168
Size:100μL Price:$300
Application:WB,FC

Reactivity:Human,Mouse,Rat
Conjugate:Unconjugated
Optional conjugates: Biotin, FITC (free of charge).
See other 26 conjugates.

Gene Name:GIRK1
Category: Recombinant Monoclonal Antibody Tags: , , , , , ,

Summary

Production Name

GIRK1 Rabbit Monoclonal Antibody

Description

Recombinant rabbit monoclonal antibody

Host

Rabbit

Application

WB,FC

Reactivity

Human,Mouse,Rat

 

Performance

Conjugation

Unconjugated

Modification

Unmodified

Isotype

IgG

Clonality

Monoclonal

Form

Liquid

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Buffer

Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% protective protein. Stable for 12 months from date of receipt.

Purification

Affinity Purification

 

Immunogen

Gene Name

GIRK1

Alternative Names

KGA; GIRK1; KIR3.1

Gene ID

3760

SwissProt ID

P48549

 

Application

Dilution Ratio

WB 1:1000-1:5000,FC 1:100-1:500

Molecular Weight

Calculated MW:57 kDa; Observed MW:57 kDa

 

Background

Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and plays an important role in regulating heartbeat. It associates with three other G-protein-activated potassium channels to form a heteromultimeric pore-forming complex that also couples to neurotransmitter receptors in the brain and whereby channel activation can inhibit action potential firing by hyperpolarizing the plasma membrane. These multimeric G-protein-gated inwardly-rectifying potassium (GIRK) channels may play a role in the pathophysiology of epilepsy, addiction, Down's syndrome, ataxia, and Parkinson's disease. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, May 2012]

 

Research Area

   💬 WhatsApp